Compound reference
Browse compound and formulation references, identity notes and research summaries. Sequence details, residue links and calculated properties appear where a documented sequence is available.
- 43
- Compounds
- 11
- Research areas
- 18
- Residues covered
43 compounds shown
5-Amino-1MQ
5-Amino-1-methylquinolinium
5-Amino-1MQ refers to 5-amino-1-methylquinolinium, a small-molecule scaffold studied as an NNMT inhibitor.
- Residues
- Not a peptide. not applicable: Amino-acid residue count is not applicable to this non-peptide molecular structure.
- Average mass
- 159.21 Da. verified: Reference form: 5-amino-1-methylquinolinium cation only, C10H11N2+; chloride, iodide and other counterions are excluded; formula C10H11N2+. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not applicable. not applicable: A sequence-derived peptide pI is not applicable. Small-molecule ionization/pKa and solution pH are different properties; no small-molecule isoelectric model is asserted.
Acetic acid water 0.6%
Acetic Acid Water 0.6% is a labelled dilute aqueous formulation.
- Residues
- Formulation. not applicable: Acetic acid in water is a solvent formulation, not a single peptide or a molecule with one molecular mass. A single residue count is not applicable.
- Average mass
- Formulation-dependent. not applicable: No single-compound molecular mass exists for this formulation. Component masses and composition would need separate specification; concentration is not molecular mass.
- pI
- Not applicable. not applicable: A formulation has no single sequence-derived peptide pI. Its solution pH is a different, composition-dependent property.
Adamax: identity reference
Adamax is a catalogue name for which a complete product structure has not been verified.
- Residues
- Not established. unverified: Identity/chemical-form specification required. No primary structural specification was established for the Adamax designation. Semax is a comparator, not a verified identity for Adamax.
- Average mass
- Not established. unverified: Identity/chemical-form specification required. No primary structural specification was established for the Adamax designation. Semax is a comparator, not a verified identity for Adamax.
- pI
- Not established. unverified: Identity/chemical-form specification required. No primary structural specification was established for the Adamax designation. Semax is a comparator, not a verified identity for Adamax.
AHK-Cu
Ala-His-Lys copper complex
AHK-Cu is the copper complex of alanyl-histidyl-lysine.
- Residues
- 3. verified: 3 residues per peptide ligand; this is not an assertion about ligand-to-copper stoichiometry.
- Average mass
- Not established. unverified: No unique average molecular mass assigned without a specified AHK–Cu coordination/protonation/salt form. The retrieved PubChem name match includes hydrochloride and is not adopted as the reference by assumption.
- pI
- Not established. unverified: Metal binding changes protonation and charge. A free GHK/AHK peptide pI does not describe the copper complex; no validated complex-specific model or measured value was established.
AICAR (AICA ribonucleoside)
Aicar
AICAR commonly denotes AICA ribonucleoside in AMPK experiments.
- Residues
- Not a peptide. not applicable: Amino-acid residue count is not applicable to this non-peptide molecular structure.
- Average mass
- 258.23 Da. verified: Reference form: AICA ribonucleoside/acadesine, C9H14N4O5; not phosphorylated AICAR/ZMP; formula C9H14N4O5. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not applicable. not applicable: A sequence-derived peptide pI is not applicable. Small-molecule ionization/pKa and solution pH are different properties; no small-molecule isoelectric model is asserted.
AOD9604
AOD9604 is a modified peptide derived from the C-terminal region of human growth hormone.
- Residues
- 16. verified: 16 main-chain residues in the published reference structure; disulfide changes mass and ionization, not residue count.
- Average mass
- 1,815.1 Da. verified: Reference form: AOD9604 reference cyclic-disulfide peptide YLRIVQCRSVEGSCGF (Cys7–Cys14), free termini; not its reduced dithiol form.; formula C78H123N23O23S2. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
BAC water: benzyl alcohol 0.9%
BAC Water (Benzyl Alcohol 0.9%) is a labelled aqueous formulation, not a peptide.
- Residues
- Formulation. not applicable: Benzyl-alcohol-containing water is a solvent formulation, not a single peptide or a molecule with one molecular mass. A single residue count is not applicable.
- Average mass
- Formulation-dependent. not applicable: No single-compound molecular mass exists for this formulation. Component masses and composition would need separate specification; concentration is not molecular mass.
- pI
- Not applicable. not applicable: A formulation has no single sequence-derived peptide pI. Its solution pH is a different, composition-dependent property.
BPC-157
BPC157
BPC-157 is a synthetic pentadecapeptide studied in tissue-injury models and cultured cells.
- Residues
- 15. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 1,419.54 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 4.03 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Cagrilintide
Cagrilintide is a long-acting, lipidated amylin analogue.
- Residues
- 37. verified: 37 main-chain residues. The gamma-glutamyl lipidation spacer is excluded from this chain count but included in the full molecular mass.
- Average mass
- 4,409 Da. verified: Reference form: Cagrilintide reference amylin analogue: 37-residue main chain, Cys2–Cys7 disulfide, C-terminal prolinamide and N-terminal C20 diacid through gamma-glutamyl spacer. Not its hydrochloride salt.; formula C194H312N54O59S2. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Cagrilintide + Semaglutide: CagriSema reference
The Aminos CagriSema listing names cagrilintide and semaglutide.
- Residues
- Multiple components. not applicable: A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide.
- Average mass
- Mixture-dependent. not applicable: There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass.
- pI
- Not applicable. not applicable: A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct.
CJC-1295 with DAC
CJC 1295 with DAC
CJC-1295 with DAC is an albumin-binding growth hormone-releasing factor analogue.
- Residues
- 30. verified: 30 residues: the substituted 29-residue GRF chain plus the added C-terminal DAC-bearing lysine. The maleimide group is not a residue.
- Average mass
- 3,647.2 Da. verified: Reference form: CJC-1295 with DAC, unbound reference molecule: modified GRF(1–29) plus a terminal Lys bearing maleimidopropionamide; not the albumin conjugate or the without-DAC designation.; formula C165H269N47O46. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
CJC-1295 without DAC
CJC1295 (Without DAC)
The catalogue designation CJC1295 without DAC must be kept separate from the albumin-binding CJC-1295 tested in the original long-acting studies.
- Residues
- Not established. unverified: Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.
- Average mass
- Not established. unverified: Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.
- pI
- Not established. unverified: Identity/chemical-form specification required. The without-DAC designation does not by itself establish a unique sequence and terminal chemistry. The original CJC-1295 paper concerns a DAC-bearing molecule; its numeric properties must not be copied here.
CJC-1295 without DAC + Ipamorelin
This blend names CJC1295 without DAC and Ipamorelin.
- Residues
- Multiple components. not applicable: A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide.
- Average mass
- Mixture-dependent. not applicable: There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass.
- pI
- Not applicable. not applicable: A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct.
DSIP
Delta sleep-inducing peptide
DSIP stands for delta sleep-inducing peptide.
- Residues
- 9. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 848.81 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 4.09 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Epitalon
Epithalon
Epitalon and Epithalon are alternative names used for the AEDG tetrapeptide.
- Residues
- 4. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 390.35 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 3.67 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
GHK-Cu
Copper tripeptide-1
GHK-Cu is a copper complex of glycyl-histidyl-lysine.
- Residues
- 3. verified: 3 residues per peptide ligand; this is not an assertion about ligand-to-copper stoichiometry.
- Average mass
- 401.91 Da. verified: Reference form: 1:1 neutral GHK–Cu chelate, no counterion; formula C14H22CuN6O4. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: Metal binding changes protonation and charge. A free GHK/AHK peptide pI does not describe the copper complex; no validated complex-specific model or measured value was established.
Glow Stack: BPC157 + TB500 + GHK-Cu
Glow Stack names BPC157, TB500 and the copper-peptide complex GHK-CU.
- Residues
- Multiple components. not applicable: A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide.
- Average mass
- Mixture-dependent. not applicable: There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass.
- pI
- Not applicable. not applicable: A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct.
Glutathione
GSH
Glutathione is a glutamate-cysteine-glycine tripeptide with a gamma-glutamyl linkage.
- Residues
- 3. verified: 3 amino-acid residues, including the gamma-glutamyl linkage; not a conventional alpha-linked E-C-G model.
- Average mass
- 307.33 Da. verified: Reference form: Reduced glutathione (GSH), gamma-L-glutamyl-L-cysteinylglycine; not oxidized glutathione (GSSG).; formula C10H17N3O6S. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
IGF-1 LR3
Long R3 IGF-I
IGF-1 LR3 is an insulin-like growth factor analogue with altered interactions with IGF-binding proteins.
- Residues
- 83. verified: 83 residues in the GSRS reference chain: mature 70-residue IGF-I domain plus a 13-residue N-terminal extension.
- Average mass
- 9,111.45 Da. calculated: Average neutral mass calculated from the GSRS 83-residue sequence with free termini, subtracting six H atoms for three disulfides; no salts/solvates. The registry’s separate estimated mass/formula are inconsistent with this explicit calculation and are not used.
- pI
- Not established. unverified: No full disulfide-aware pI model or documented value was established. A calculator treating the six disulfide cysteines as free thiols would not represent this reference structure.
Ipamorelin
Ipamorelin is a synthetic growth hormone secretagogue.
- Residues
- 5. verified: 5 residues, including Aib and D-2-naphthylalanine; no substitution of canonical letters for these noncanonical residues.
- Average mass
- 711.9 Da. verified: Reference form: Ipamorelin: Aib–His–D-2-Nal–D-Phe–Lys-NH2; free peptide moiety, without an unspecified counterion.; formula C38H49N9O5. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Kisspeptin-10
KP-10
Kisspeptin-10 is a short kisspeptin fragment studied in reproductive endocrinology.
- Residues
- 10. verified: 10 peptide-chain residues; C-terminal amide is not an extra residue.
- Average mass
- 1,302.4 Da. verified: Reference form: Human kisspeptin-10, YNWNSFGLRF-NH2; C-terminally amidated peptide, without acetate or other counterion.; formula C63H83N17O14. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Klow Stack: BPC157 + TB500 + GHK-Cu + KPV
Klow Stack names four components: BPC157, TB500, GHK-CU and KPV.
- Residues
- Multiple components. not applicable: A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide.
- Average mass
- Mixture-dependent. not applicable: There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass.
- pI
- Not applicable. not applicable: A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct.
KPV
Lys-Pro-Val
KPV is the Lys-Pro-Val tripeptide investigated in inflammation models.
- Residues
- 3. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 342.43 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 8.75 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
L-Carnitine
Levocarnitine
L-Carnitine is an amino-acid-derived metabolite, not a peptide or a standard protein-building amino acid.
- Residues
- Not a peptide. not applicable: Amino-acid residue count is not applicable to this non-peptide molecular structure.
- Average mass
- 161.20 Da. verified: Reference form: L-carnitine zwitterion, C7H15NO3; not a tartrate, hydrochloride or acetylcarnitine; formula C7H15NO3. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not applicable. not applicable: A sequence-derived peptide pI is not applicable. Small-molecule ionization/pKa and solution pH are different properties; no small-molecule isoelectric model is asserted.
Lipo-C: formulation reference
Lipo-C is a formulation name, not a defined single molecule.
- Residues
- Formulation. not applicable: Lipo-C is a formulation name without a verified complete ingredient specification; no single molecular entity is assigned. A single residue count is not applicable.
- Average mass
- Formulation-dependent. not applicable: No single-compound molecular mass exists for this formulation. Component masses and composition would need separate specification; concentration is not molecular mass.
- pI
- Not applicable. not applicable: A formulation has no single sequence-derived peptide pI. Its solution pH is a different, composition-dependent property.
Melanotan I (afamelanotide)
Afamelanotide
Melanotan I is a name associated with afamelanotide, an alpha-MSH analogue.
- Residues
- 13. verified: 13 peptide-chain residues; modifications and any counterion are not extra residues.
- Average mass
- 1,646.8 Da. verified: Reference form: Afamelanotide/Melanotan I reference N-acetylated, C-terminally amidated peptide containing norleucine and D-Phe; acetate is excluded.; formula C78H111N21O19. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Melanotan II
MT-II
Melanotan II is a cyclic alpha-MSH analogue.
- Residues
- 7. verified: 7 amino-acid residues; acetylation, amidation and side-chain cyclization do not add chain residues.
- Average mass
- 1,024.2 Da. verified: Reference form: Melanotan II reference N-acetylated, C-terminally amidated cyclic heptapeptide with norleucine, D-Phe and Asp–Lys lactam linkage.; formula C50H69N15O9. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
MOTS-c
MOTS-C
MOTS-c is a mitochondria-derived peptide investigated in metabolic signalling.
- Residues
- 16. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 2,174.59 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 10.27 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
NAD+
Nicotinamide adenine dinucleotide, oxidized
NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a nucleotide cofactor.
- Residues
- Not a peptide. not applicable: Amino-acid residue count is not applicable to this non-peptide molecular structure.
- Average mass
- 663.4 Da. verified: Reference form: oxidized NAD+ reference structure, C21H27N7O14P2 (CID 5892); not NADH or an unspecified salt; formula C21H27N7O14P2. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not applicable. not applicable: A sequence-derived peptide pI is not applicable. Small-molecule ionization/pKa and solution pH are different properties; no small-molecule isoelectric model is asserted.
Oxytocin
Oxytocin Acetate
Oxytocin is a disulfide-containing nonapeptide hormone.
- Residues
- 9. verified: 9 residues in the cyclic-disulfide, C-terminally amidated reference peptide.
- Average mass
- 1,007.2 Da. verified: Reference form: Oxytocin with Cys1–Cys6 disulfide and C-terminal glycinamide; peptide moiety only, not an unspecified acetate/hydrate.; formula C43H66N12O12S2. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Pinealon
Glu-Asp-Arg
Pinealon is the Glu-Asp-Arg tripeptide investigated in experimental oxidative-stress models.
- Residues
- 3. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 418.40 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 4.37 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
PT-141 (bremelanotide)
PT141
PT-141 is a name associated with bremelanotide, a cyclic melanocortin peptide analogue.
- Residues
- 7. verified: 7 main-chain residues in the reference cyclic peptide, including noncanonical norleucine and D-Phe.
- Average mass
- 1,025.2 Da. verified: Reference form: Bremelanotide/PT-141 reference cyclic peptide (free peptide moiety); not its acetate salt and not the distinct C-terminally amidated Melanotan II.; formula C50H68N14O10. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Retatrutide
LY3437943
Retatrutide, also called LY3437943, is a single peptide agonist of GIP, GLP-1 and glucagon receptors.
- Residues
- 39. verified: 39 main-chain residues, including noncanonical residues. Lipid and gamma-glutamyl/ether linker are excluded from chain length but included in the molecular mass.
- Average mass
- 4,731 Da. verified: Reference form: Retatrutide/LY3437943: 39-residue main chain, including Aib and alpha-methyl-L-leucine, C-terminal amide and Lys17-linked C20 diacid/linker. Full modified reference molecule, not the unmodified registry sequence.; formula C221H342N46O68. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Selank
Tuftsin analogue
Selank is a synthetic peptide related to tuftsin.
- Residues
- 7. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 751.87 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 11.00 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Semaglutide
GLP-1 analogue
Semaglutide is a lipid-modified GLP-1 receptor agonist.
- Residues
- 31. verified: 31 main-chain residues, including Aib; lipid/linker moieties are not counted as additional main-chain residues.
- Average mass
- 4,113.58 Da. verified: Sponsor-label molecular weight for semaglutide, C187H291N45O59, including its covalent modifications. Average molecular mass, not monoisotopic mass. Excludes unlisted counterions and formulation excipients; not an Aminos lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Semax
ACTH-fragment analogue
Semax is an ACTH-fragment analogue investigated in neurological research.
- Residues
- 7. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 813.92 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 5.22 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Sermorelin acetate
Sermorelin
Sermorelin is associated with the amidated GRF(1–29) fragment.
- Residues
- 29. verified: 29 peptide-chain residues, with C-terminal amidation; acetate is not a residue.
- Average mass
- 3,357.9 Da. verified: Reference form: Sermorelin peptide moiety, GRF(1–29)-NH2; acetate salt stoichiometry/hydration is not specified, so the reference mass excludes acetate and water of hydration.; formula C149H246N44O42S. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
SNAP-8
Acetyl octapeptide-3
SNAP-8 is associated with the cosmetic ingredient name acetyl octapeptide-3.
- Residues
- 8. verified: 8 residues; N-acetyl and C-terminal amide groups are modifications, not additional residues.
- Average mass
- 1,075.2 Da. verified: Reference form: Acetyl octapeptide-3 reference Ac–EEMQRRAD–NH2 (PubChem CID 76283482); named SNAP-8 here. Alternative synonym records do not establish lot identity.; formula C41H70N16O16S. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
SS-31
Elamipretide
SS-31 is a modified tetrapeptide investigated for interactions with mitochondrial cardiolipin.
- Residues
- 4. verified: 4 residues, including D-Arg and noncanonical dimethyltyrosine.
- Average mass
- 639.8 Da. verified: Reference form: SS-31/elamipretide reference D-Arg–2,6-dimethyl-Tyr–Lys–Phe-NH2; peptide moiety, excluding acetate or chloride.; formula C32H49N9O5. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
TB-500 fragment
Ac-Tβ4(17–23)
This reference describes the N-acetylated thymosin beta-4 fragment Ac-LKKTETQ identified in published TB-500 analytical work.
- Residues
- Not established. unverified: Identity/chemical-form specification required. TB-500 is an ambiguous catalogue designation. A primary analytical paper identified acetylated thymosin-beta4(17–23) in its tested sample; that does not identify this lot or justify choosing between that fragment and full thymosin-beta4.
- Average mass
- Not established. unverified: Identity/chemical-form specification required. TB-500 is an ambiguous catalogue designation. A primary analytical paper identified acetylated thymosin-beta4(17–23) in its tested sample; that does not identify this lot or justify choosing between that fragment and full thymosin-beta4.
- pI
- Not established. unverified: Identity/chemical-form specification required. TB-500 is an ambiguous catalogue designation. A primary analytical paper identified acetylated thymosin-beta4(17–23) in its tested sample; that does not identify this lot or justify choosing between that fragment and full thymosin-beta4.
Tesamorelin
Tesamorelin is a growth hormone-releasing hormone analogue studied in endocrine and metabolic research.
- Residues
- 44. verified: 44 peptide-chain residues; the N-terminal hexenoyl substituent is not a residue.
- Average mass
- 5,135.9 Da. verified: Sponsor-label molecular weight for tesamorelin free-base equivalent, C221H366N72O67S, including its covalent modifications. Average molecular mass, not monoisotopic mass. Excludes unlisted counterions and formulation excipients; not an Aminos lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Tirzepatide
LY3298176
Tirzepatide is a single modified peptide that activates GIP and GLP-1 receptors.
- Residues
- 39. verified: 39 main-chain residues, including both Aib residues; lipid/linker moieties are excluded from chain length and included in molecular mass.
- Average mass
- 4,813.53 Da. verified: Sponsor-label molecular weight for tirzepatide, C225H348N48O68, including its covalent modifications. Average molecular mass, not monoisotopic mass. Excludes unlisted counterions and formulation excipients; not an Aminos lot measurement.
- pI
- Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.
Wolverine Stack: BPC157 + TB500
Wolverine Stack is the catalogue blend of BPC157 and TB500.
- Residues
- Multiple components. not applicable: A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide.
- Average mass
- Mixture-dependent. not applicable: There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass.
- pI
- Not applicable. not applicable: A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct.
No compounds match that area or search.
Explore a sequence and its residues.
Follow individual residues to their amino acid references, or paste a sequence into the sequence tool to calculate properties for an unmodified linear peptide.